As momentum builds, London’s 2026 global event announces leading voices shaping the worldwide future of healthspan.
The Longevity Show has released its first slate of speakers, offering an early glimpse of the depth and breadth of expertise set to converge in London next June. Designed as a meeting point for geroscientists, clinicians, technologists and the increasingly longevity-literate public, the Show aims to bridge cutting-edge research with practical tools for healthier, longer lives.
With anticipation building around this inaugural event, the initial speaker announcement signals a program that is as diverse as it is ambitious, spanning biological age clocks, precision diagnostics, women’s midlife health, AI-enabled prevention and the changing economics of aging.
Longevity.Technology: As the longevity landscape gathers pace, what stands out about this first wave of speakers is not simply their individual expertise but the growing sense that healthy longevity has outgrown its siloed adolescence; geroscientists are now shoulder-to-shoulder with AI builders, policy thinkers and cultural storytellers, and that cross-pollination signals a field ready to move from promise to practice. Biological age clocks are edging closer to clinical utility, prevention is finally being recognized as an economic imperative rather than a lifestyle flourish, and the tools of personalization – once reserved for quantified-self enthusiasts – are beginning to permeate mainstream healthcare.
It is tempting to view this as the sector’s coming-of-age moment, yet the more interesting truth is that these conversations reveal both how much progress has been made and how wide the deployment gap remains; breakthroughs count for little if they do not translate to real-world access, whether that is in NHS memory clinics, community health settings or the everyday choices people make about midlife and beyond. Bringing this constellation of voices together is therefore more than a speaker announcement – it is a signal that longevity is shifting from an abstract ideal to a practical, cultural and economic reality, one that demands scrutiny, ambition and, occasionally, a raised eyebrow when enthusiasm races ahead of evidence.
Leaders in geroscience
Professor Andrea Maier brings decades of translational research experience, with more than 350 peer-reviewed publications and international leadership roles spanning Europe, Australia and Asia. Her work focuses on the mechanisms of aging and age-related disease, drawing together observational cohorts and intervention trials to probe how aging can be modified.
Her appearance at the Show will provide scientific ballast for discussions on how biological mechanisms map to clinical impact, especially as longevity medicine inches closer to clinical consensus.
Measuring biological age
Few names carry as much weight in aging science as Dr Steve Horvath, creator of the Horvath epigenetic clock. His work catalyzed the modern biomarker revolution, opening the door to more precise measurement of biological aging and expanding the field’s capacity to test and refine interventions.
Horvath’s presence underscores the Show’s emphasis on bridging molecular insight with real-world tools.
Slowing cognitive decline
As CEO of Brain+, Devika Wood leads the global rollout of Ayla, a digital version of Cognitive Stimulation Therapy that has demonstrated cognitive and quality-of-life benefits across multiple international trials and is recommended by NICE and WHO.
Her work sits at the intersection of digital therapeutics, dementia care and health equity – a reminder that longevity must be accessible, not just aspirational.
Personalized health data
Scientist-entrepreneur Dr Gil Blander integrates biomarkers, wearables, nutrition and AI through InsideTracker to provide personalized, actionable health insights for more than 100,000 users.
His focus on data-driven prevention reflects a broader sectoral shift toward continuous monitoring and practical, behavior-linked intervention.
Lifestyle medicine
Dr Rangan Chatterjee, known for his four-pillar lifestyle framework and BBC series Doctor in the House, brings a clinical perspective focused on prevention, behavioral change and patient empowerment.
His mainstream reach and evidence-grounded approach provide a bridge between academic longevity research and everyday health habits.
Reframing midlife
Journalist and Noon founder Eleanor Mills has championed a cultural rethink of midlife, arguing for a more constructive narrative around the “second half” of a longer life.
Through her writing and community platform, she explores how identity, opportunity and health intersect in an era where 100-year lives are increasingly plausible.
AI and the future of health
Broadcaster Lara Lewington, long-time presenter on the BBC’s Click, focuses on how AI is reshaping health, aging and public understanding of emerging technologies.
Her work demystifies complex systems and interrogates both promise and risk, an essential perspective as AI becomes embedded in diagnostics and self-management tools.
Moonshot thinking
Entrepreneur Naveen Jain, founder of Viome, brings a characteristically expansive vision for personalized health, leveraging mRNA analysis and AI to inform nutrition, diagnostics and preventive strategies.
His long-standing interest in ambitious technological leaps positions him as a provocative voice in the program.
Commercializing longevity science
Chris Mirabile, Founder and CEO of NOVOS, brings a perspective shaped by the challenge of translating longevity science into consumer-ready interventions. His work focuses on developing evidence-informed formulations that target the hallmarks of aging, while navigating the regulatory, scientific and educational hurdles that accompany any attempt to bring geroscience to the public.
His contribution will help illuminate how companies are positioning themselves in a rapidly evolving market and what responsible commercialization in this space should look like.
Health, movement and motivation
Popular Peloton instructor Leanne Hainsby, a former professional dancer who has performed with artists including Katy Perry and Taylor Swift, brings a perspective rooted in motivation, adherence and the emotional architecture that shapes long-term health behaviors.
Her contribution highlights the growing recognition that sustainable lifestyle change relies not only on knowledge but on connection, support and the ability to translate intention into daily practice.
Framing the ambition
Phil Newman, cofounder of the Longevity Show and Longevity.Technology CEO, said: “This is a moment we’ve been building toward for several years; the field is now mature enough, confident enough and evidence-driven enough to host an event that welcomes experts and the public into the same conversation. The speakers we’re announcing today reflect that breadth and ambition – and there is much more to come. We’re only at the start of revealing the full program, and the momentum gathering behind this first edition is already exceeding expectations.”
A horizon widening
Healthy longevity is now a question of science, policy and culture, and the Longevity Show’s first wave of speakers suggests that all three will be given room to breathe. As the sector navigates its next chapter, the event promises to be a timely gathering point for those shaping what longer, healthier lives might realistically look like.
The Longevity Show opens its doors on 26–27 June 2026 at Tobacco Dock, London. Early bird tickets for all tiers are now available at www.longevityshow.com until 28 February 2026.
